Antiphospholipid antibodies and atherosclerosis
Authors:
- Marc MonestierMMMarc Monestier
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 112 (2) , 183-189
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?Immunobiology, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Inflammation and AtherosclerosisCirculation, 2002
- Epitope Studies with Anti-β2-glycoprotein I Antibodies from Autoantibody and Immunized SourcesJournal of Autoimmunity, 2000
- Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunityJournal of Clinical Investigation, 2000
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.Journal of Clinical Investigation, 1996
- Increased Autoantibody Titers Against Epitopes of Oxidized LDL in LDL Receptor–Deficient Mice With Increased AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Vascular disease in the antiphospholipid syndrome: A comparison with the patient population with atherosclerosisJournal of Vascular Surgery, 1992
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- (NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction.Journal of Experimental Medicine, 1981